Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy

Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy

<p>Abstract</p> <p>Background</p> <p>Myocardial fibrosis is frequently identified in patients with hypertrophic cardiomyopathy (HCM). The aim of this study was to investigate the role of myocardial fibrosis detected by late gadolinium-enhancement (LGE) cardiovascular ma...

Full description

Bibliographic Details
Main Authors:	Germans Tjeerd, Sueselbeck Tim, Schoenberg Stefan O, Haghi Dariusch, Veltmann Christian, Doesch Christina, Wolpert Christian, Kuschyk Jürgen, Fluechter Stephan, Streitner Florian, Borggrefe Martin, Papavassiliu Theano
Format:	Article
Language:	English
Published:	Elsevier 2010-05-01
Series:	Journal of Cardiovascular Magnetic Resonance
Online Access:	http://www.jcmr-online.com/content/12/1/30

Similar Items

Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention.
by: Florian Streitner, et al.
Published: (2013-01-01)

The relationship between the severity of coronary artery disease and epicardial adipose tissue depends on the left ventricular function.
by: Christina Doesch, et al.
Published: (2012-01-01)

Incremental benefit of late gadolinium cardiac magnetic resonance imaging for risk stratification in patients with hypertrophic cardiomyopathy
by: Christina Doesch, et al.
Published: (2017-07-01)

Right ventricular function quantification in Takotsubo cardiomyopathy using two-dimensional strain echocardiography.
by: Felix Heggemann, et al.
Published: (2014-01-01)

The Association between the Extent of Late Gadolinium Enhancement and Diastolic Dysfunction in Hypertrophic Cardiomyopathy
by: Deniz Alis, et al.
Published: (2021-04-01)

Dual tachyarrhythmia: Ventricular fibrillation induced by atrial tachyarrhythmia in a patient with hypertrophic cardiomyopathy
by: Takahiko Kinjo, et al.
Published: (2024-02-01)

A pilot study for risk stratification of ventricular tachyarrhythmia in hypertrophic cardiomyopathy with routine echocardiography parameters
by: Anselm A. Derda, et al.
Published: (2024-02-01)

The extent of late gadolinium enhancement can be assessed fast and reproducible using semi-quantitative method in patients with hypertrophic cardiomyopathy
by: Gommans Frank, et al.
Published: (2013-01-01)

Prevalence, Clinical Characteristics, and Predictors of Patients with Thromboembolic Events in Takotsubo Cardiomyopathy
by: Ibrahim El-Battrawy, et al.
Published: (2016-01-01)

Prevalence, Clinical Characteristics, and Predictors of Patients with Thromboembolic Events in Takotsubo Cardiomyopathy
by: Ibrahim El-Battrawy, et al.
Published: (2016-07-01)

Reproducibility of Gadolinium Enhancement Patterns and Wall Thickness in Hypertrophic Cardiomyopathy
by: Gaston A. Rodriguez-Granillo, et al.
Published: (2016-01-01)

Further refining risk in hypertrophic cardiomyopathy with late gadolinium enhancement by CMR
by: Kramer, C, et al.
Published: (2018)

Clinical significance of late gadolinium enhancement in pediatric patients with hypertrophic cardiomyopathy
by: Smith Brandon M, et al.
Published: (2013-01-01)

Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness
by: Götte Marco, et al.
Published: (2009-01-01)

Risk stratification of patients with Brugada syndrome: the impact of myocardial strain analysis using cardiac magnetic resonance feature trackingBrief summary
by: Anna Hohneck, et al.
Published: (2021-09-01)

Late gadolinium enhancement as an independent predictor of atrial fibrillation in hypertrophic cardiomyopathy (HCM)
by: Dawson Dana, et al.
Published: (2009-01-01)

Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype
by: Jassal Davinder S, et al.
Published: (2008-12-01)

Late gadolinium enhancement location assessed by magnetic resonance and arrhythmogenic risk in hypertrophic cardiomyopathy
by: Ana Raquel Barbosa, et al.
Published: (2020-11-01)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?
by: Kyoung-Min Park, et al.
Published: (2016-01-01)

Impact of left atrial appendage morphology on thrombus formation after successful left atrial appendage occlusion: Assessment with cardiac-computed-tomography
by: Wulf Dieker, et al.
Published: (2018-01-01)

Septal myocardial scar burden predicts the response to cardiac contractility modulation in patients with heart failure
by: Uzair Ansari, et al.
Published: (2022-11-01)

Utility of late gadolinium enhancement on magnetic resonance imaging in hypertrophic cardiomyopathy patients in an Indian cohort
by: Harikrishnan Gangadharakaimal, et al.
Published: (2023-09-01)

Correlation between septal midwall late gadolinium enhancement on CMR and conduction delay on ECG in patients with nonischemic dilated cardiomyopathy
by: Marthe A.J. Becker, et al.
Published: (2020-02-01)

Toward replacing late gadolinium enhancement with artificial intelligence virtual native enhancement for gadolinium-free cardiovascular magnetic resonance tissue characterization in hypertrophic cardiomyopathy
by: Zhang, Q, et al.
Published: (2021)

MicroRNA-1 downregulation increases connexin 43 displacement and induces ventricular tachyarrhythmias in rodent hypertrophic hearts.
by: Antonio Curcio, et al.
Published: (2013-01-01)

Late gadolinium enhancement cardiovascular magnetic resonance for sudden cardiac death risk stratification in hypertrophic cardiomyopathy
by: Ismail Tevfik F, et al.
Published: (2013-01-01)

The Combination of Feature Tracking and Late Gadolinium Enhancement for Identification Between Hypertrophic Cardiomyopathy and Hypertensive Heart Disease
by: Shengliang Liu, et al.
Published: (2022-05-01)

High sensitivity of late gadolinium enhancement for predicting microscopic myocardial scarring in biopsied specimens in hypertrophic cardiomyopathy.
by: Tetsuo Konno, et al.
Published: (2014-01-01)

Radiomics in Cardiac Computed Tomography
by: Isabelle Ayx, et al.
Published: (2023-01-01)

Treatment of fetus with tachyarrhythmia
by: Daniela Katić, et al.
Published: (2023-01-01)

TACHYARRHYTHMIAS IN PATIENTS WITH CANCER
by: E G Chelombit'ko, et al.
Published: (2017-12-01)

Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long‐Term Follow‐Up
by: Boris Rudic, et al.
Published: (2017-10-01)

Focal ischemic myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy
by: Yang Zhi, et al.
Published: (2024-04-01)

Patterns of Left Ventricular Hypertrophy and Late Gadolinium Enhancement onCardiac Magnetic Resonanace in Patients with Hypertrophic Cardiomyopathy
by: Sobia Mehreen, et al.
Published: (2022-11-01)

The effect of inhibition of the Na<sup>+</sup>/H<sup>+</sup> exchanger on the development of hypertrophy in hypertrophic cardiomyopathy
by: van der Velden Jolanda, et al.
Published: (2011-02-01)

Distinct Metabolomic Signatures in Preclinical and Obstructive Hypertrophic Cardiomyopathy
by: Maike Schuldt, et al.
Published: (2021-10-01)

Cardiomiopatia hipertrófica e taquiarritmias detectadas por marcapasso Cardiomiopatía hipertrófica y taquiarritmias detectadas por marcapaso Hypertrophic cardiomyopathy and tachyarrhythmias detected by a pacemaker
by: Adrian Baranchuk, et al.
Published: (2009-03-01)

Statin therapy is associated with improved survival in patients with ventricular tachyarrhythmias
by: Jonas Rusnak, et al.
Published: (2019-05-01)

Management of tachyarrhythmia during pregnancy
by: Emily Ann Enderlin, et al.
Published: (2017-03-01)

Devices for Prevention of Atrial Tachyarrhythmias
by: Ignacio Fernández Lozano, et al.
Published: (2004-04-01)